87
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets

, , , , &
Pages 1267-1272 | Published online: 19 Apr 2017

References

  • AgarwalRGuptaSKAgarwalPSaxenaRAgrawalSSCurrent concepts in the pathophysiology of glaucomaIndian J Ophthalmol2009574 257 26619574692
  • SugiyamaTMoriyaSOkuHAzumaIAssociation of endothelin-1 with normal tension glaucoma: clinical and fundamental studiesSurv Ophthalmol199539Suppl 1 S49 S567660312
  • GassAFlammerJLinderLRomerioSCGasserPHaefeliWEInverse correlation between endothelin-1-induced peripheral microvascular vasoconstriction and blood pressure in glaucoma patientsGraefes Arch Clin Exp Ophthalmol199723510 634 6389349947
  • NoskeWHensenJWiederholtMEndothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataractGraefes Arch Clin Exp Ophthalmol19972359 551 5529342603
  • TezelGKassMAKolkerAEBeckerBWaxMBPlasma and aqueous humor endothelin levels in primary open-angle glaucomaJ Glaucoma199762 83 899098815
  • OrgulSPrunteCFlammerJEndothelium-derived vasoactive substances relevant to normal-tension glaucomaCurr Opin Ophthalmol199892 88 9410180520
  • CioffiGASullivanPThe effect of chronic ischemia on the primate optic nerveEur J Ophthalmol19999Suppl 1 S34 S3610230604
  • DranceSMSome factors in the production of low tension glaucomaBr J Ophthalmol1972563 229 2425032759
  • BeggISDranceSMSweeneyVPIschaemic optic neuropathy in chronic simple glaucomaBr J Ophthalmol1971552 73 905550539
  • DranceSMSweeneyVPMorganRWFeldmanFStudies of factors involved in the production of low tension glaucomaArch Ophthalmol1973896 457 4654706442
  • HoyngPFGreveELFrederikseKGeijssenCOostingHPlatelet aggregation and glaucomaDoc Ophthalmol1985612 167 1734075960
  • HoyngPFde JongNOostingHStilmaJPlatelet aggregation, disc haemorrhage and progressive loss of visual fields in glaucoma. A seven year follow-up study on glaucomaInt Ophthalmol1992162 65 731587697
  • SchroerHScheurerGBehrens-BaumannWVascular occlusion of the retina – an experimental model. II. Platelet aggregatesGraefes Arch Clin Exp Ophthalmol19922303 281 2851597296
  • BoerrigterRMSiertsemaJVKemaIPSerotonin (5-HT) and the rat’s eye. Some pilot studiesDoc Ophthalmol1992821–2 141 1501305018
  • BojicLSkare-LibrenjakLCirculating platelet aggregates in glaucomaInt Ophthalmol1998223 151 15410548459
  • MatsumotoMMatsuhashiHNakazawaMNormal tension glaucoma and primary open angle glaucoma associated with increased platelet aggregationTohoku J Exp Med20011934 293 29911453537
  • MoschosMMChatziralliIPStamatakisGPapakonstantinouVDTsatsosMDemopoulosCAIn vitro effects of anti-glaucomatous eye drops on platelet-activating factor and its metabolismSemin Ophthalmol2017322 198 20326270771
  • DemopoulosCAPinckardRNHanahanDJPlatelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)J Biol Chem197925419 9355 9358489536
  • BojicLMandicZBukovicDKarelovicDStrinicTCirculating platelet aggregates and progression of visual field loss in glaucomaColl Antropol2002262 589 59312528286
  • YauJWTeohHVermaSEndothelial cell control of thrombosisBMC Cardiovasc Disord201515 13026481314
  • BudenzDLAndersonDRFeuerWJDetection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment StudyOphthalmology200611312 2137 214316996592
  • ShimSHKimJMWooHYShinKUKohJWParkKHAssociation between platelet function and disc hemorrhage in patients with normal-tension glaucoma: a prospective cross-sectional studyAm J Ophthalmol20151606 1191 119926384167
  • SonnsjoBDokmoYKrakauTDisc haemorrhages, precursors of open angle glaucomaProg Retin Eye Res2002211 35 5611906810
  • KrakauCEBengtssonBHolminCThe glaucoma theory updatedActa Ophthalmol (Copenh)1983615 737 7416659881
  • YamagishiSMatsuiTPigment epithelium-derived factor (PEDF) and cardiometabolic disordersCurr Pharm Des20142014 2377 238623844817
  • YamagishiSIMatsuiTAnti-atherothrombogenic properties of PEDFCurr Mol Med2010103 284 29120236055
  • YamagishiSMatsuiTNakamuraKTakenakaKPigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levelsInt J Cardiol20101401 121 12219046781
  • YamagishiSMatsuiTNakamuraKTakenakaKAdministration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in ratsClin Exp Med200991 73 7618815870
  • TakenakaKYamagishiSMatsuiTPigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromesAtherosclerosis20081971 25 3317850801
  • OgataNMatsuokaMImaizumiMArichiMMatsumuraMDecreased levels of pigment epithelium-derived factor in eyes with neuroretinal dystrophic diseasesAm J Ophthalmol20041376 1129 113015183804
  • HamanakaTBillAPlatelet aggregation on the endothelium of Schlemm’s canalExp Eye Res1994593 249 2567821369
  • MehraKSDubeBMikuniIDubeRKReduced fibrinolytic activity in aqueous humor of chronic simple glaucomaTokai J Exp Clin Med198491 33 346535299
  • MehraKSDubeBDubeRKReduced fibrinolytic activity in aqueous humour in glaucomaIndian J Ophthalmol1983315 592 5936671769
  • MehraKSDubeBDubeRKFibrinolytic activity in blood and aqueous humour in glaucomaIndian J Ophthalmol198331Suppl 827 8296544262
  • PacheMFlammerJA sick eye in a sick body? Systemic findings in patients with primary open-angle glaucomaSurv Ophthalmol2006513 179 21216644363